These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2714069)

  • 1. Symposium: new findings on the antibacterial interactions between cefotaxime and desacetylcefotaxime.
    Diagn Microbiol Infect Dis; 1989; 12(1):23-121. PubMed ID: 2714069
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
    Neu HC
    Rev Infect Dis; 1982; 4 Suppl():S374-8. PubMed ID: 6294786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
    Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
    Jones RN; Barry AL; Thornsberry C
    Rev Infect Dis; 1982; 4 Suppl():S366-73. PubMed ID: 6294785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review.
    Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):19-33. PubMed ID: 7587039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
    Jones RN; Barry AL
    Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime.
    Molinari G; Saverino D; Paglia P; Debbia EA; Schito GC
    J Chemother; 1991 Feb; 3(1):6-12. PubMed ID: 2019866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs.
    Jones RN
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():39-43. PubMed ID: 6094461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro evaluation of the activity and interactions of cefotaxime and its metabolite desacetylcefotaxime against strains of enterobacteria, staphylococci and Bacteroides fragilis isolated from hospital infections].
    Pitzus E
    G Ital Chemioter; 1989; 36(1-3):57-64. PubMed ID: 2488914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of cefotaxime, desacetylcefotaxime, and the combination of the two.
    Friis H
    Diagn Microbiol Infect Dis; 1989; 12(1):67-72. PubMed ID: 2714074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of cefotaxime and desacetylcefotaxime, alone or in combination, against gram-positive cocci.
    Cruciani M; Navarra A; Di Perri G; Danzi MC; Concia E; Bassetti D
    Drugs Exp Clin Res; 1990; 16(11):565-8. PubMed ID: 2101779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive and synergistic bactericidal activity contributed by desacetylcefotaxime during cefotaxime therapy.
    Moore ES; Jimenez M; Barriere SL; Cimino ML; Fekety FR
    Clin Pharm; 1988 Dec; 7(12):901-5. PubMed ID: 3208502
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
    Aldridge KE; Sanders CV; Marier RL
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro studies on cefotaxime and desacetylcefotaxime.
    Selwyn S; Bakhtiar M
    Drugs Exp Clin Res; 1986; 12(12):953-65. PubMed ID: 3494587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime.
    Quintiliani R; Nightingale CH; Tilton R
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desacetylcefotaxime--another broad spectrum cephalosporin?
    Fuchs PC; Jones RN; Barry AL; Allen SD; Ayers LW; Pfaller M
    J Antimicrob Chemother; 1989 Jan; 23(1):165-7. PubMed ID: 2745252
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime.
    Fuchs PC; Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(1):81-5. PubMed ID: 2714075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of the activity of cefotaxime and desacetylated cefotaxime and of their combination.
    Nanetti A; La Placa M
    J Chemother; 1990 Jun; 2(3):159-63. PubMed ID: 2380765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli.
    Marone P; Navarra A; Monzillo V; Traverso A
    Drugs Exp Clin Res; 1990; 16(12):629-33. PubMed ID: 2130005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of cefotaxime and desacetylcefotaxime into brain abscesses in humans.
    Sjölin J; Eriksson N; Arneborn P; Cars O
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2606-10. PubMed ID: 1810195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.